Evidence map›Paper›PMID 29949679›Full record

ReviewCancer science2018

Tetraploidy in cancer and its possible link to aging.

Kozo Tanaka, Hidemasa Goto, Yuhei Nishimura, Kousuke Kasahara, Akira Mizoguchi, Masaki Inagaki

Open access · goldAbstract readReview
In one paragraph

Review in Cancer science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Cell-cell fusion in cancer: The next cancer hallmark?The international journal of biochemistry & cell biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. miR-186 induces tetraploidy in arsenic exposed human keratinocytes.Ecotoxicology and environmental safety · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kozo TanakaDepartment of Molecular Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.ORCID http://orcid.org/0000-0001-6086-2858
Hidemasa GotoDepartment of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Japan.
Yuhei NishimuraDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Japan.
Kousuke KasaharaDepartment of Physiology, Mie University Graduate School of Medicine, Tsu, Japan.
Akira MizoguchiDepartment of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Japan.
Masaki InagakiDepartment of Physiology, Mie University Graduate School of Medicine, Tsu, Japan.
Mie University · JPTohoku University · JP

Funding

Japan Society for the Promotion of Science 15H02398Japan Society for the Promotion of Science 15H04368Japan Society for the Promotion of Science 15K08324Japan Society for the Promotion of Science 16H01296Japan Society for the Promotion of Science 16H06461Japan Society for the Promotion of Science 16K08547Japan Society for the Promotion of Science 16K14604Japan Society for the Promotion of Science 17K08269Japan Society for the Promotion of Science 18H02434Japan Society for the Promotion of Science 18H04896Japan Society for the Promotion of Science 18K06927Naito FoundationTakeda Science Foundation
6 · The paper itself

Abstract

Tetraploidy, a condition in which a cell has four homologous sets of chromosomes, is often seen as a natural physiological condition but is also frequently seen in pathophysiological conditions such as cancer. Tetraploidy facilitates chromosomal instability (CIN), which is an elevated level of chromosomal loss and gain that can cause production of a wide variety of aneuploid cells that carry structural and numerical aberrations of chromosomes. The resultant genomic heterogeneity supposedly expedites karyotypic evolution that confers oncogenic potential in spite of the reduced cellular fitness caused by aneuploidy. Recent studies suggest that tetraploidy might also be associated with aging; mice with mutations in an intermediate filament protein have revealed that these tetraploidy-prone mice exhibit tissue disorders associated with aging. Cellular senescence and its accompanying senescence-associated secretory phenotype have now emerged as critical factors that link tetraploidy and tetraploidy-induced CIN with cancer, and possibly with aging. Here, we review recent findings about how tetraploidy is related to cancer and possibly to aging, and discuss underlying mechanisms of the relationship, as well as how we can exploit the properties of cells exhibiting tetraploidy-induced CIN to control these pathological conditions.

Indexed as

TetraploidyAgingAnimalsCellular SenescenceChromosomal InstabilityHumansMiceNeoplasmsaginganeuploidycancerchromosomal instabilitysenescencesenescence-associated secretory phenotypetetraploidy

Identifiers

PMID29949679
PMCPMC6125447
OpenAlexW2810322589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.